Most Patients With Cancer-Associated Dermatomyositis Have Antibodies to Nuclear Matrix Protein NXP-2 or Transcription Intermediary Factor 1γ

Anti-Melanoma Differentiation-Associated Protein 5-Associated Dermatomyositis: Expanding the Clinical Spectrum

(2013) John C. Hall et al.   ARTHRITIS CARE & RESEARCH

Anti-NXP2 autoantibodies in adult patients with idiopathic inflammatory myopathies: possible association with malignancy

(2012) Yuki Ichimura et al.   ANNALS OF THE RHEUMATIC DISEASES

Myositis autoantibodies

(2012) Livia Casciola-Rosen et al.   CURRENT OPINION IN RHEUMATOLOGY

Development of an ELISA for detection of autoantibodies to nuclear matrix protein 2

(2012) A. Ishikawa et al.   RHEUMATOLOGY

Anti-MJ/NXP-2 autoantibody specificity in a cohort of adult Italian patients with polymyositis/dermatomyositis

(2012) Angela Ceribelli et al.   ARTHRITIS RESEARCH & THERAPY

Clinical Correlations With Dermatomyositis-Specific Autoantibodies in Adult Japanese Patients With Dermatomyositis

(2011) Yasuhito Hamaguchi et al.   ARCHIVES OF DERMATOLOGY

Myositis-specific anti-155/140 autoantibodies target transcription intermediary factor 1 family proteins

(2011) Manabu Fujimoto et al.   ARTHRITIS AND RHEUMATISM

Usefulness of anti-p155 autoantibody for diagnosing cancer-associated dermatomyositis: A systematic review and meta-analysis

(2011) Ernesto Trallero-Araguás et al.   ARTHRITIS AND RHEUMATISM

Analysis of dermatomyositis-specific autoantibodies and clinical characteristics in Japanese patients

(2011) Nobuaki IKEDA et al.   JOURNAL OF DERMATOLOGY

The mucocutaneous and systemic phenotype of dermatomyositis patients with antibodies to MDA5 (CADM-140): A retrospective study

(2011) David Fiorentino et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Anti-MDA5 antibody is associated with A/SIP and decreased T cells in peripheral blood and predicts poor prognosis of ILD in Chinese patients with dermatomyositis

(2011) Fang Chen et al.   RHEUMATOLOGY INTERNATIONAL

Novel autoantibodies and clinical phenotypes in adult and juvenile myositis

(2011) Zoe E Betteridge et al.   ARTHRITIS RESEARCH & THERAPY

Incidence of Dermatomyositis and Clinically Amyopathic Dermatomyositis

(2010) Margo J. Bendewald et al.   ARCHIVES OF DERMATOLOGY

Myositis autoantibodies in Korean patients with inflammatory myositis: Anti-140-kDa polypeptide antibody is primarily associated with rapidly progressive interstitial lung disease independent of clinically amyopathic dermatomyositis

(2010) Eun Ha Kang et al.   BMC MUSCULOSKELETAL DISORDERS

Anti-MDA5 and anti-TIF1-γ antibodies have clinical significance for patients with dermatomyositis

(2010) Kei Hoshino et al.   RHEUMATOLOGY

RNA helicase encoded by melanoma differentiation-associated gene 5 is a major autoantigen in patients with clinically amyopathic dermatomyositis: Association with rapidly progressive interstitial lung disease

(2009) Shinji Sato et al.   ARTHRITIS AND RHEUMATISM

Autoantibodies to a 140-kd protein in juvenile dermatomyositis are associated with calcinosis

(2009) H. Gunawardena et al.   ARTHRITIS AND RHEUMATISM

Defining cancer risk in dermatomyositis. Part I

(2009) V. Madan et al.   CLINICAL AND EXPERIMENTAL DERMATOLOGY

Clinical and Serologic Characterization of an Argentine Pediatric Myositis Cohort: Identification of a Novel Autoantibody (anti-MJ) to a 142-kDa Protein

(2009) G. ESPADA et al.   JOURNAL OF RHEUMATOLOGY

The RIG-I-like receptor IFIH1/MDA5 is a dermatomyositis-specific autoantigen identified by the anti-CADM-140 antibody

(2009) Ran Nakashima et al.   RHEUMATOLOGY